Major histocompatibility complex class I molecules are down-regulated at the cell surface by the K5 protein encoded...

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• Kaposi's sarcoma-associated herpesvirus (KSHV) is linked to various cancers.
• Major histocompatibility complex class I (MHC-I) molecules are crucial for immune surveillance.
• Viral evasion of host immunity is a key factor in pathogenesis.

Purpose of the Study:

• To investigate the effect of KSHV K5 gene expression on MHC-I molecule cell surface presentation.
• To determine if KSHV K5 impacts MHC-I synthesis or post-translational processing.
• To explore the role of MHC-I down-regulation in KSHV-associated diseases.

Main Methods:

• Cell culture (BC-3, HeLa) with KSHV infection or K5 gene transfection.
• Immunoprecipitation using anti-MHC-I antibodies.
• Pulse-chase analysis with endoglycosidase H digestion.
• Immunohistological examination of KSHV-associated disease tissues.

Main Results:

• Down-regulation of cell surface MHC-I observed in KSHV-infected and K5-transfected cells.
• No significant reduction in MHC-I molecule synthesis was detected.
• MHC-I molecules were stable and transported correctly from the endoplasmic reticulum to the Golgi apparatus.
• K5 antigen was present in Kaposi's sarcoma, primary effusion lymphoma, and Castleman's disease tissues.

Conclusions:

• KSHV K5 gene expression leads to the down-regulation of cell surface MHC-I.
• This down-regulation occurs post-translationally, not through reduced synthesis.
• The K5-mediated MHC-I evasion mechanism likely contributes to KSHV's ability to escape host immune responses.